Around one in five adults would share weight-loss jabs with friends, survey finds A Pharmacy2U-commissioned survey also found that more than one-quarter of UK adults said that they would share oral weight-loss medication with friends or family.…
Pharmaceutical companies in talks with NICE about access to Alzheimer’s drugs Drug manufacturers Lilly and Eisai are in discussion with the National Institute for Health and Care Excellence to appeal the regulator’s rejection of the use of donanemab and lecanemab on the NHS for the third time in June 2025.…
Pharmacy Inside Jobs: sports pharmacist Mark Stuart explains how he went from pharmacist volunteer to superintendent of the Olympic Games and reveals the key role pharmacists play in supporting athletes.…
MenB vaccine supply ‘bolstered’ for NHS England pharmacy campaign NHS England has said that under its meningitis B vaccination service, around 135,000 bookings were made for the jab during the first week of the campaign’s launch.…
Post-finasteride syndrome: pharmacists must lead the conversation on patient safety We would not accept a tooth-whitening procedure that carried a risk of suicide, persistent sexual dysfunction and irreversible neurological harm. Why is it being accepted with finasteride?…
Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair loss The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
People with MS in England to be given fampridine as patent expires Fampridine, taken twice daily, improves nerve signalling and walking speed in some patients with multiple sclerosis.…
Negotiator to challenge prime minister on business rates relief Community Pharmacy England said it had made a “clear case” for business rates relief during funding negotiations and will put these arguments to Andy Burnham's government.…
Everything you need to know about clinical trial legislation changes Clinical trial legislation has been overhauled to speed up set-up times and include a broader range of healthcare professionals, but what do the reforms mean for patients and pharmacists?…
Novo Nordisk sues Eli Lilly over ‘misleading’ GLP-1 advertising Novo Nordisk claims that Lilly’s advertising campaigns intentionally used outdated studies to offer “proof of broad, product-level superiority” of its Zepbound and Mounjaro products over Novo Nordisk’s Wegovy and Ozempic products.…
